JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia

被引：12

作者：

Zecca, M. ^{[1
]}

Bergamaschi, G.

Kratz, C.

Bergstraesser, E.

Danesino, C.

De Filippi, P.

Hasle, H.

Lisini, D.

Locatelli, F.

Pession, A.

Sainati, L.

Stary, J.

Trebo, M.

机构：

[1] Univ Pavia, Fdz IRCCS, Policlin San Matteo, Pavia, Italy

[2] Policlin San Matteo, Fdz IRCCS, Dept Internal Med, Pavia, Italy

[3] Univ Freiburg, Div Pediat Hematol & Oncol, Dept Pediat & Adolescent Med, Freiburg, Germany

[4] Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland

[5] Aarhus Univ Hosp Skejiby, Dept Pediat, Aarhus, Denmark

[6] Univ Bologna, Policlin St Orsola, Bologna, Italy

[7] Univ Padua, Padua, Italy

[8] Univ Hosp Motol, Prague, Czech Republic

[9] St Anna Childrens Hosp, Dept Pediat, Vienna, Austria

[10] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands

[11] Dutch Childhood Oncol Grp, Hagen, Germany

[12] Dept Pediat Hematol Oncol, Wroclaw, Poland

来源：

LEUKEMIA | 2007年 / 21卷 / 02期

关键词：

D O I：

10.1038/sj.leu.2404484

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：367 / 369

页数：4

共 14 条

[1] Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [J].

Chen, C-Y ;

Lin, L-I ;

Tang, J-L ;

Tsay, W. ;

Chang, H-H ;

Yeh, Y-C ;

Huang, C-F ;

Chiou, R-J ;

Yao, M. ;

Ko, B-S ;

Chen, Y-C ;

Lin, K-H ;

Lin, D-T ;

Tien, H-F .

LEUKEMIA, 2006, 20 (06) :1155-1158

[2] RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML) [J].

Flotho, C ;

Valcamonica, S ;

Mach-Pascual, S ;

Schmahl, G ;

Corral, L ;

Ritterbach, J ;

Hasle, H ;

Aricò, M ;

Biondi, A ;

Niemeyer, CM .

LEUKEMIA, 1999, 13 (01) :32-37

[3] JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia [J].

Jelinek, J ;

Oki, Y ;

Gharibyan, V ;

Bueso-Ramos, C ;

Prchal, JT ;

Verstovsek, S ;

Beran, M ;

Estey, E ;

Kantarjian, HM ;

Issa, JPJ .

BLOOD, 2005, 106 (10) :3370-3373

[4] A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].

Kralovics, R ;

Passamonti, F ;

Buser, AS ;

Teo, S ;

Tiedt, R ;

Passweg, JR ;

Tichelli, A ;

Cazzola, M ;

Skoda, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790

[5] Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia [J].

Kratz, CP ;

Böll, S ;

Kontny, U ;

Schrappe, M ;

Niemeyer, CM ;

Stanulla, M .

LEUKEMIA, 2006, 20 (02) :381-383

[6] Somatic inactivation of Nfl in hematopoietic cells results in a progressive myeloproliferative disorder [J].

Le, DT ;

Kong, N ;

Zhu, Y ;

Lauchle, JO ;

Aiyigari, A ;

Braun, BS ;

Wang, E ;

Kogan, SC ;

Le Beau, MM ;

Parada, L ;

Shannon, KM .

BLOOD, 2004, 103 (11) :4243-4250

[7] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J].

Levine, RL ;

Wadleigh, M ;

Cools, J ;

Ebert, BL ;

Wernig, G ;

Huntly, BJP ;

Boggon, TJ ;

Wlodarska, L ;

Clark, JJ ;

Moore, S ;

Adelsperger, J ;

Koo, S ;

Lee, JC ;

Gabriel, S ;

Mercher, T ;

D'Andrea, A ;

Fröhling, S ;

Döhner, K ;

Marynen, P ;

Vandenberghe, P ;

Mesa, RA ;

Tefferi, A ;

Griffin, JD ;

Eck, MJ ;

Sellers, WR ;

Meyerson, M ;

Golub, TR ;

Lee, SJ ;

Gilliland, DG .

CANCER CELL, 2005, 7 (04) :387-397

[8] Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML):: results of the EWOG-MDS/EBMT trial [J].

Locatelli, F ;

Nöllke, P ;

Zecca, M ;

Korthof, E ;

Lanino, E ;

Peters, C ;

Pession, A ;

Kabisch, H ;

Uderzo, C ;

Bonfim, CS ;

Bader, P ;

Dilloo, D ;

Stary, J ;

Fischer, A ;

Révész, T ;

Führer, M ;

Hasle, H ;

Trebo, M ;

van den Heuvel-Eibrink, MM ;

Fenu, S ;

Strahm, B ;

Giorgiani, G ;

Bonora, MR ;

Duffner, U ;

Niemeyer, CM .

BLOOD, 2005, 105 (01) :410-419

[9] Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations [J].

Mohi, MG ;

Williams, IR ;

Dearolf, CR ;

Chan, G ;

Kutok, JL ;

Cohen, S ;

Morgan, K ;

Boulton, C ;

Shigematsu, H ;

Keilhack, H ;

Akashi, K ;

Gilliland, DG ;

Neel, BG .

CANCER CELL, 2005, 7 (02) :179-191

[10]

Niemeyer CM, 1997, BLOOD, V89, P3534

← 1 2 →